Rxivist logo

A role for vitamin D and omega-3 fatty acids in major depression? An exploration using genomics

By Yuri Milaneschi, Wouter J. Peyrot, Michel G. Nivard, Hamdi Mbarek, Dorret I Boomsma, Brenda Penninx

Posted 09 Jan 2019
bioRxiv DOI: 10.1101/516013 (published DOI: 10.1038/s41398-019-0554-y)

Background: Trials testing the effect of vitamin D or omega-3 fatty acids (n3-PUFA) supplementation on major depressive disorder (MDD) reported conflicting findings. These trials were boosted by epidemiological evidence suggesting an inverse association of circulating 25-hydroxyvitamin D (25-OH-D) and n3-PUFA levels with MDD. Observational associations may emerge from unresolved confounding, shared genetic risk, or direct causal relationships. We explored the nature of these associations exploiting data and statistical tools from genomics. Methods: Results from GWAS on 25-OH-D (N=79366), n3-PUFA (N=24925) and MDD (135458 cases, 344901 controls) were applied to individual-level data (>2,000 subjects with measures of genotype, DSM-IV lifetime MDD diagnoses and circulating 25-OH-D and n3-PUFA) and summary-level data analyses. Shared genetic risk between traits was tested by polygenic risk scores (PRS). Two-sample Mendelian Randomization (2SMR) analyses tested the potential bidirectional causality between traits. Outcome: In individual-level data, PRS were associated with the phenotype of the same trait (PRS 25-OH-D p=1.4e-20, PRS N3-PUFA p=9.3e-6, PRS MDD p=1.4e-4), but not with the other phenotypes, suggesting a lack of shared genetic effects. In summary-level data, 2SMR analyses provided no evidence of a causal role on MDD of 25-OH-D (p=0.50) or n3-PUFA (p=0.16), or for a causal role of MDD on 25-OH-D (p=0.25) or n3-PUFA (p=0.66). Conclusions: Applying genomics tools indicated that that shared genetic risk or direct causality between 25-OH-D, n3-PUFA and MDD is unlikely: unresolved confounding may explain the associations reported in observational studies. These findings represent a cautionary tale for testing supplementation of these compounds in preventing or treating MDD.

Download data

  • Downloaded 478 times
  • Download rankings, all-time:
    • Site-wide: 35,802 out of 100,263
    • In genomics: 3,448 out of 6,218
  • Year to date:
    • Site-wide: 66,265 out of 100,263
  • Since beginning of last month:
    • Site-wide: None out of 100,263

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)


  • 20 Oct 2020: Support for sorting preprints using Twitter activity has been removed, at least temporarily, until a new source of social media activity data becomes available.
  • 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
  • 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
  • 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
  • 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
  • 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
  • 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
  • 22 Jan 2019: Nature just published an article about Rxivist and our data.
  • 13 Jan 2019: The Rxivist preprint is live!